Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06611384 · ClinicalTrials.gov registry record
Arrhythmias in Hemorrhagic Myocardial Infarction During the Acute Post-PCI Phase
A clinical trial, sponsored by Rohan Dharmakumar.
- Completed
- Registry status
- 250
- Enrollment target
NCT06611384: Completed study, sponsored by Rohan Dharmakumar.
NCT06611384 is a clinical trial that has completed, run by Rohan Dharmakumar. The registered enrollment target is 250 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06611384 has completed, sponsored by Rohan Dharmakumar.
- COMPLETED
- Registry status
- 250 participants
- Enrollment target
Study Summary
Prevalence of Arrhythmias in Hemorrhagic Myocardial Infarction During the Acute Post-PCI Phase
Primary Outcome
Prevalence of Premature Ventricular Contractions (PVCs), Non-Sustained Ventricular Tachycardia (NSVT), and Ventricular Tachycardia/Ventricular Fibrillation (VT/VF) detected by post-PCI Holter monitoring.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2022-06-01 |
| Est. Completion | 2025-03-30 |
What the finished NCT06611384 record still lists
NCT06611384 is an observational study that tracks outcomes without assigning an intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT06611384 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06611384 about?
NCT06611384 is a clinical study titled "Arrhythmias in Hemorrhagic Myocardial Infarction During the Acute Post-PCI Phase". Prevalence of Arrhythmias in Hemorrhagic Myocardial Infarction During the Acute Post-PCI Phase
What is the current status of trial NCT06611384?
This trial is currently completed. The enrollment target is 250 participants. The study started on 2022-06-01. Estimated completion is 2025-03-30.
Who is sponsoring clinical trial NCT06611384?
This trial is sponsored by Rohan Dharmakumar, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00483249 · 250 participants · NA
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- NCT00777712 · 250 participants
Mechanisms Underlying Impaired Diabetic Wound Healing
- NCT01451502 · 250 participants · NA
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- NCT01771718 · 250 participants
Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI